LOS ANGELES - RadNet, Inc. (NASDAQ: RDNT), a prominent provider of outpatient diagnostic imaging services, disclosed plans today for a public offering of $200 million in common stock, with the possibility of an additional $30 million contingent on underwriter demand. The completion and specifics of this offering depend on market conditions and cannot be guaranteed.
The company, which operates a substantial network of imaging centers across several U.S. states, aims to allocate the net proceeds for general corporate purposes and to potentially finance future acquisitions. The offering is conducted under a shelf registration statement approved by the Securities and Exchange Commission (SEC).
Jefferies and Raymond James are managing the bookrunning process. Details regarding the offering, including a preliminary prospectus supplement, will be accessible through the SEC's website and from the bookrunners' offices.
While the announcement outlines the intended use of funds and the process of the offering, it also includes cautionary language about forward-looking statements, reminding investors that actual outcomes may vary due to numerous risk factors.
This news is based on a press release statement and does not constitute an offer to sell or a solicitation of an offer to buy securities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.